Rayonier Advanced Materials (RYAM) reported third-quarter 2025 results highlighting operational resilience and progress toward long-term growth objectives.
The company posted net sales of $353 million, down $48 million year-over-year, and a loss from continuing operations of $4 million—an improvement of $29 million compared with 2024.
Adjusted EBITDA from continuing operations reached $42 million, with the company maintaining its full-year 2025 guidance of $135 to $140 million, including a $12 million non-cash environmental charge recorded earlier in the year.
President and CEO De Lyle Bloomquist said the quarter “reflects the strength of RYAM’s core business and the resilience of our teams executing through a dynamic backdrop.” He noted continued normalization in Cellulose Specialties demand, improved order trends, and greater stability across operations and costs.
The company ended the quarter with $140 million in global liquidity and a net secured leverage ratio of 4.1 times covenant EBITDA. Working-capital improvements are expected to generate $25 to $30 million in adjusted free cash flow in Q4.
RYAM continues to target over $300 million in run-rate EBITDA by 2027, supported by multi-year pricing actions, $30 million in cost reductions by 2026, and incremental efficiency gains. Management reiterated its focus on maximizing cash generation, managing working capital, and maintaining financial flexibility.
Rayonier Advanced Materials (RYAM) is a global leader in cellulose-based technologies. Its high-purity cellulose specialties are key ingredients in filters, food, pharmaceuticals, and various industrial applications. The company also produces biofuels, bioelectricity, lignin-based biomaterials, and paperboard products used in packaging. With operations in the United States, Canada, and France, RYAM generated $1.6 billion in revenue in 2024.
